Bilateral hemorrhagic occlusive retinal vasculitis and panuveitis following intravitreal faricimab injection: A clinicopathologic case study

Read full text
Authors: Negin Yavari, Ankur Gupta, Andreas Mitsios, Jia-Horung Hung, Dalia El-Feky, Celine Dan-Tam Nguyen, Çigdem Yaşar, Frances Andrea Añover, Aim-On Saengsirinavin, Azadeh Mobasserian, Amir Akhavanrezayat, Osama Elaraby
+7 more Xiaoyan Zhang, Ngoc Trong Tuong Than, Anna Bettina Toth, Daniel R. Agarwal, Jonathan Lin, Christopher Chi Mong Or, Quan Dong Nguyen
Cited by: 1
References: 17

Abstract

Purpose: To describe the clinicopathological study of severe bilateral intraocular inflammation following intravitreal (IVT) injection of faricimab in a patient with neovascular age-related macular degeneration (nAMD). Observation: An 80-year-old Caucasian female with bilateral nAMD presented with blurry vision and ocular pain after receiving bilateral IVT injections of faricimab on separate days from different lots. The patient experienced significant reduction in her visual acuity, from 20/40 to counting-fingers in the right eye and from 20/50 to hand-motion in the left eye; intraocular pressure (IOP) was elevated in both eyes at 48 mmHg and 49 mmHg. Anterior segment examination revealed bilateral diffuse mutton-fat keratic precipitates and fundus examination revealed bilateral vitreous opacities. Fluorescein angiography demonstrated optic disc leakage and bilateral hemorrhagic occlusive vasculitis. Following initial management with systemic corticosteroid, a subsequent unilateral subconjunctival dexamethasone implant, and pars plana vitrectomy, ocular inflammation subsided significantly along with the normalization of IOP. Cytology examination of vitreous samples showed the presence of chronic inflammatory cells in the vitreous. Conclusion: The case highlights the clinical presentation, detailed findings, and successful treatment strategy for hemorrhagic occlusive retinal vasculitis and panuveitis induced by IVT injection of faricimab. Cytopathology analysis of vitreous samples provides novel insights regarding inflammatory mechanisms underlying this rare but potentially sight-threatening complication.

Fields of Study & Subjects

Ocular Diseases and Behçet’s Syndrome Retinal Diseases and Treatments Retinal and Optic Conditions

Publication details

Journal / source
American Journal of Ophthalmology Case Reports
Publisher
Elsevier BV
Volume
41
Pages
102532–102532
Publication date
29 January 2026
Language
EN